SOM
SOMNOMED LIMITED
$0.3100
▼ -3.13%
Market cap
$68M
Turnover
$13,565
Last price
$0.3100
Day change
-3.13%
Announcements
3
Range, past year
Open 0.750 · Low 0.300 · Now 0.310 · High 0.945
Open SOM in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
SOM momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
26/100
Wyckoff phase
Accumulation22d
Trend stage
Neutral
1 Day
-3.1%
1 Week
-6.1%
1 Month
-7.5%
1 Year
-58.7%
RSI
34
Avg daily range
5.2%
SOMNOMED LIMITED scores 26 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 22 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently matching and the institutional accumulation signal reads low.
What stands out
- Trend R² 0.82 — highly linear uptrend
Points to watch
- 60d drawdown -43.6%
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
SOM announcements
Recent price-sensitive releases.
- 2026-08-28 Investor presentation Company Presentation | Preliminary Final Report
- 2026-08-28 Full year results announcement FY26 Web Cast | Preliminary Final Report
- 2026-08-28 Full Year Statutory Accounts Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
More Health Care stocks
Most traded in the same sector.